GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » EV-to-Revenue

10x Genomics (MEX:TXG) EV-to-Revenue : 3.00 (As of Oct. 31, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 10x Genomics's enterprise value is MXN33,781 Mil. 10x Genomics's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was MXN11,254 Mil. Therefore, 10x Genomics's EV-to-Revenue for today is 3.00.

The historical rank and industry rank for 10x Genomics's EV-to-Revenue or its related term are showing as below:

MEX:TXG' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.46   Med: 11.06   Max: 68.76
Current: 2.68

During the past 7 years, the highest EV-to-Revenue of 10x Genomics was 68.76. The lowest was 2.46. And the median was 11.06.

MEX:TXG's EV-to-Revenue is ranked worse than
61.27% of 661 companies
in the Healthcare Providers & Services industry
Industry Median: 1.76 vs MEX:TXG: 2.68

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-10-31), 10x Genomics's stock price is MXN440.00. 10x Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was MXN94.03. Therefore, 10x Genomics's PS Ratio for today is 4.68.


10x Genomics EV-to-Revenue Historical Data

The historical data trend for 10x Genomics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics EV-to-Revenue Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 28.24 49.39 33.14 7.48 10.30

10x Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.81 10.30 6.74 3.25 3.84

Competitive Comparison of 10x Genomics's EV-to-Revenue

For the Health Information Services subindustry, 10x Genomics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


10x Genomics's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where 10x Genomics's EV-to-Revenue falls into.



10x Genomics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

10x Genomics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=33781.468/11254.071
=3.00

10x Genomics's current Enterprise Value is MXN33,781 Mil.
10x Genomics's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN11,254 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


10x Genomics  (MEX:TXG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

10x Genomics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=440.00/94.03
=4.68

10x Genomics's share price for today is MXN440.00.
10x Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN94.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


10x Genomics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of 10x Genomics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.